News

Jennifer R. Grandis, MD, senior author of the study. Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found. Non-steroidal anti-inflammatory drugs

“The Grand Challenge is designed to address really big, intractable questions in cancer. The idea is not to make small, incremental steps, but to make a huge leap forward.” Thea Tlsty, PhD Related news: Q & A with Thea Tlsty, PhD, on Leading International Team to Study Inflammation and Cancer UC San

In laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach. Traditionally, targeted cancer therapies aim to disable proteins borne of cancer-driving genes. Instead, the UCSF scientists prevented these proteins

Using a divide and conquer strategy, researchers from the University of California San Francisco have provided a road map for the development of a precision medicine approach to osteosarcoma, the most common bone cancer in children and young adults and an aggressive disease for which treatment has

The amount of radiation that patients are exposed to from computed tomography (CT) scans varies widely between institutions and countries, and is largely due to differences in the technical settings of the scanning machines at each institution, according to an international study led by UC San

A landmark mammography study has found that women who receive annual breast cancer screenings will have a lower mortality rate and will benefit more from therapy upon diagnosis of breast cancer. The lead investigator on this study was László Tabár, MD. He and his team analyzed data from the Swedish

UCSF staffers distribute t-shirts at the campus launch event for UCSF: The Campaign in 2017. From left to right: Toshonna Ross, Peggy Huey, Krista Dow and Dresden Joswig. Photo by Elisabeth Fall In the year since announcing an ambitious, $5 billion fundraising campaign, UC San Francisco has seen